Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04616534
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+19 more
National Cancer Institute (NCI) 14
Large-scale testing (Phase 3)Study completedNCT00089570
What this trial is testing

Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

Who this might be right for
Hepatorenal Syndrome
Mallinckrodt 112
Early research (Phase 1)Study completedNCT04686669
What this trial is testing

A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet Formulations

Who this might be right for
Relative Bioavailability
Forendo Pharma Ltd 12
Early research (Phase 1)Study completedNCT01761773
What this trial is testing

A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function

Who this might be right for
HealthyRenal Impairment
Exelixis 32
Testing effectiveness (Phase 2)Study completedNCT05378269
What this trial is testing

Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA

Who this might be right for
Vulvar Atrophy
Daré Bioscience, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT00005056
What this trial is testing

Bryostatin 1 In Treating Patients With Progressive Kidney Cancer

Who this might be right for
Kidney Cancer
Cancer Research UK
Not applicableStudy completedNCT02370394
What this trial is testing

Intervention for IPV Perinatal Women- RCT

Who this might be right for
Intimate Partner Violence
Women and Infants Hospital of Rhode Island 53
Early research (Phase 1)Study completedNCT01297205
What this trial is testing

Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia

Who this might be right for
Bronchopulmonary Dysplasia
Medipost Co Ltd. 9
Large-scale testing (Phase 3)Looking for participantsNCT05457283
What this trial is testing

Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Who this might be right for
Chronic Kidney DiseaseProteinuriaChildren
Bayer 100
Not applicableUnknownNCT01912703
What this trial is testing

The Long-term Neurodevelopmental Outcome After Intraventricular Hemorrhage (IVH)-Grades I-II in Preterm Infants at Ages 1-7 Years

Who this might be right for
Premature Infants
Hillel Yaffe Medical Center 700
Large-scale testing (Phase 3)Active Not RecruitingNCT04700124
What this trial is testing

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 808
Early research (Phase 1)Study completedNCT01634503
What this trial is testing

Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06305767
What this trial is testing

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 230
Early research (Phase 1)Not Yet RecruitingNCT03463239
What this trial is testing

Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora

Who this might be right for
Urologic DiseasesMale Urogenital DiseasesPenile Diseases+3 more
Wake Forest University Health Sciences 10
Large-scale testing (Phase 3)Study completedNCT03069365
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 101
Not applicableStudy completedNCT02162277
What this trial is testing

Therapeutic Strategy in Postmenopausal Women Using Osteoporotic Diagnostic Kits

Who this might be right for
Osteoporosis
Shinshu University 1,000
Testing effectiveness (Phase 2)Study completedNCT01121406
What this trial is testing

BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Boehringer Ingelheim 110
Testing effectiveness (Phase 2)Study completedNCT00664781
What this trial is testing

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
Cancer Research UK 78
Not applicableStudy completedNCT01436877
What this trial is testing

Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia

Who this might be right for
Bladder Neck ObstructionBenign Prostate Hyperplasia
Medi-Tate Ltd. 32
Early research (Phase 1)Study completedNCT01100619
What this trial is testing

A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors

Who this might be right for
Papillary Thyroid CancerFollicular Thyroid CancerHuerthle Cell Thyroid Cancer+1 more
Exelixis 40
Next Page